Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

56
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
56
Tumor Progression02:07

Tumor Progression

7.6K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.6K
Cancer Survival Analysis01:21

Cancer Survival Analysis

805
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
805

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of Neck Dissection on Infrahyoid and Suprahyoid Muscle Dimensions in Head and Neck Cancer.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·2026
Same author

Impact of Generative AI on Operative Planning in Otolaryngology Residents.

Surgical innovation·2026
Same author

Pathologic and radiologic response to neoadjuvant therapy in advanced differentiated thyroid cancer.

European thyroid journal·2026
Same author

Students Are Ready for AI-But Is Medical Education?

The clinical teacher·2025
Same author

Evaluating large language models for specialist referral triage in primary care: a quantitative study using otolaryngology scenarios.

Family practice·2025
Same author

Surgical Outcomes Following Neoadjuvant-Targeted Therapy for Advanced Differentiated Thyroid Cancer-Real-World Data.

Clinical endocrinology·2025

Related Experiment Video

Updated: Mar 3, 2026

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
03:55

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

1.1K

Prognostic Factors in Differentiated Thyroid Cancer Revisited.

Eran Glikson1, Eran Alon1,2, Lev Bedrin1

  • 1Department of Otolaryngology, Head and Neck Surgery, Sheba Medical Center, Tel Hashomer, Israel.

The Israel Medical Association Journal : IMAJ
|May 1, 2017
PubMed
Summary

New factors like family history and molecular markers may impact differentiated thyroid carcinoma (DTC) risk. Research is exploring these potential prognostic indicators for improved DTC staging.

More Related Videos

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
06:08

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Published on: June 2, 2023

2.4K
Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy
05:12

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy

Published on: May 12, 2023

5.1K

Related Experiment Videos

Last Updated: Mar 3, 2026

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
03:55

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

1.1K
Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
06:08

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Published on: June 2, 2023

2.4K
Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy
05:12

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy

Published on: May 12, 2023

5.1K

Area of Science:

  • Endocrinology
  • Oncology
  • Medical Diagnostics

Background:

  • Differentiated thyroid carcinoma (DTC) accounts for over 90% of thyroid cancers with a high survival rate.
  • Current risk stratification systems (EORTC, AGES, AMES, MACIS) are established but may be incomplete.
  • Emerging research challenges traditional factors and identifies new potential prognostic indicators for DTC.

Purpose of the Study:

  • To review and present recent literature on novel prognostic factors for differentiated thyroid carcinoma (DTC).
  • To highlight emerging factors that may refine DTC risk stratification beyond traditional parameters.

Main Methods:

  • A comprehensive literature review and analysis of publications from the last 10 years.
  • Focus on studies investigating prognostic factors and risk stratification in DTC.

Main Results:

  • Identified potential new prognostic factors for DTC: family history, lymph node parameters, PET-CT findings, multifocal disease, thyroglobulin levels, and molecular markers (e.g., BRAF).
  • Age as a prognostic factor is being re-evaluated, with potential challenges to the 45-year cutoff.
  • The prognostic significance of male gender in DTC is debated, with conflicting study results.

Conclusions:

  • Several novel factors show potential prognostic implications for DTC.
  • Further research is needed to determine the definitive role and potential integration of these new factors into updated DTC staging systems.